What if honest drug education, harm reduction, long term integration, and acknowledging risks, took the place of propaganda?

Isn’t it just as valid and meaningful for psychedelics to be used for diversion, entertainment, relaxation, and adventure?

Last Week Tonight joined a long and growing list of media outlets that have added fuel to the hype of psychedelic medicalization. By omitting the potential risks and actual harms associated with psychedelic-assisted therapy, this messaging increases the risk to the public by presenting unrealistic expectations about experimental treatments.

We talked with Johns Hopkins psychedelic researcher, Alan Kooi Davis, about the Source Research Foundation, a non-profit awarding grants to students researching psychedelics.

Although psychedelics are going to shape the future of mental health therapy, these powerful mind-altering substances shouldn’t be taken lightly.

There’s an emerging public, political, and scientific consensus that otherwise-law-abiding people should not be arrested simply for using or possessing a drug.

The Czech Psychedelic Society is creating the Czech version of Zendo Project and KosmiCare.

The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.

This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church's sacrament and the people involved in promoting the Church and its claims.

It’s hard to imagine Trump & Sessions stuffing the toothpaste back in the tube, but remember drug prohibition is a lucrative business.